Rewiring the psoriasis–metabolism axis: therapeutic potential of saroglitazar beyond PPAR modulation
Inflammopharmacology · 2026-11 · 34 (11) · 6991-7007
DOI: 10.1007/s10787-026-02413-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 25.09.2026. Verfasst von Kanika Vashisht und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Laureate Institute of Pharmacy, Kathog, District Kangra, Himachal Pradesh, 176031, India. Hauptthemen laut MEDLINE: Psoriasis, Pyrroles, Phenylpropionates. Die Arbeit nennt 81 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Laureate Institute of Pharmacy, Kathog, District Kangra, Himachal Pradesh, 176031, India.
- Laureate Institute of Pharmacy, Kathog, District Kangra, Himachal Pradesh, 176031, India.
- Department of Pharmacology, Laureate Institute of Pharmacy, Kathog, District Kangra, Himachal Pradesh, 176031, India. shiv.kushawaha@gmail.com.
Zitieren
APA
Vashisht, K., Kumar, H., Rana, S., Ashawat, M. S., & Kushawaha, S. K. (2026). Rewiring the psoriasis–metabolism axis: therapeutic potential of saroglitazar beyond PPAR modulation. Inflammopharmacology, 34(11), 6991-7007. https://doi.org/10.1007/s10787-026-02413-0
Vancouver
Vashisht K, Kumar H, Rana S, Ashawat MS, Kushawaha SK. Rewiring the psoriasis–metabolism axis: therapeutic potential of saroglitazar beyond PPAR modulation. Inflammopharmacology. 2026;34(11):6991-7007. doi:10.1007/s10787-026-02413-0
BibTeX
@article{Vashisht2026,
author = {Vashisht, Kanika and Kumar, Himanshu and Rana, Swati and Ashawat, Mahendra Singh and Kushawaha, Shiv Kumar},
title = {Rewiring the psoriasis–metabolism axis: therapeutic potential of saroglitazar beyond PPAR modulation},
journal = {Inflammopharmacology},
year = {2026},
volume = {34},
number = {11},
pages = {6991--7007},
doi = {10.1007/s10787-026-02413-0}
}
EUVIMED